AHA voices support for bill to repeal antitrust exemption for health insurers

Aug 08, 2019 - 01:58 PM
legislation update

The AHA yesterday voiced support for the Competitive Health Insurance Reform Act (H.R. 1418/S. 350), legislation that would repeal the antitrust exemption available to commercial health insurers for anticompetitive conduct. “The AHA believes that the commercial health insurance industry should be governed by the same antitrust laws and policies that apply in other sectors of our economy, including hospitals and other health care providers,” AHA said in a letter to Sen. Steve Daines, R-Mont., and Rep. Peter DeFazio, D-Ore., the lead sponsors of the legislation. “Any exemptions should be narrow and carefully tailored to achieve a pro-competitive purpose. We have previously articulated our concerns to the Department of Justice’s Antitrust Division about the abuse of market power by large commercial insurers; this remains a concern as large commercial insurers continue attempts to consolidate to the detriment of consumers.”

Related News Articles

Headline
Survey finds prior authorization viewed as greatest hurdle in navigating health care
A KFF survey published today found that people view prior authorization as the biggest challenge beyond costs when navigating the health care system. In terms…
Headline
Senate expected to pass funding deal as partial government shutdown approaches
The Senate Jan. 30 is expected to pass a government funding plan ahead of a midnight deadline. A partial shutdown is still set to occur as the Senate changed…
Headline
AHA releases 2026 Advocacy Agenda
The AHA Jan. 28 released its 2026 Advocacy Agenda, containing the association’s key priorities for Congress, the administration, regulatory agencies and courts…
Headline
HHS OIG releases bulletin on direct-to-consumer drug sales, RFI on need for regulatory changes
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…
Headline
CMS announces drugs selected for third round of drug price negotiations
The Centers for Medicare & Medicaid Services Jan. 27 announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations.…
Headline
Analysis: MA insurers made 53 million prior authorization determinations in 2024
A KFF analysis released Jan. 28 found that Medicare Advantage insurers made nearly 53 million prior authorization determinations in 2024, an increase…